Navigation Links
Amgen's BiTE® Antibody Blinatumomab (AMG 103) Achieved High Rate of Complete Response in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
Date:5/16/2012

or the use(s) being investigated. Healthcare professionals should refer to and rely upon the FDA-approved labeling for the products, and not the information discussed in this news release.

CONTACT: Amgen, Thousand Oaks
Christine Regan, 805-447-5476 (media)
Arvind Sood, 805-447-1060 (investors)

(1) Definition of Acute lymphocytic leukemia.Mayo Clinic. http://www.mayoclinic.com/health/acute-lymphocytic-leukemia/DS00558. Accessed April 16, 2012.
(2) World. Globocan 2008 website. http://globocan.iarc.fr/factsheet.asp. Accessed May 4, 2012.
(3) Causes of Acute lymphocytic leukemia. Mayo Clinic. http://www.mayoclinic.com/health/acute-lymphocytic-leukemia/DS00558/DSECTION=causes. Accessed April 16, 2012.
(4) Symptoms of Acute lymphocytic leukemiaMayo Clinic. http://www.mayoclinic.com/health/acute-lymphocytic-leukemia/DS00558/DSECTION=symptoms. Accessed April 16, 2012.

(Logo: http://photos.prnewswire.com/prnh/20081015/AMGENLOGO)


'/>"/>
SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
2. MedImmune Announces Phase 2 Safety Data for Anti-RSV Antibody and National RSV Surveillance Results
3. Roche Announces Positive Results in Solid Tumors Using Human Monoclonal Antibody Against IGF-1R (R1507)
4. New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models
5. Raven Announces Phase 1 Clinical Trial Results of RAV12 Therapeutic Antibody for Treatment of Adenocarcinomas
6. MedImmune Initiates First Clinical Trial of Monoclonal Antibody Targeting GM-CSFR in Patients with Rheumatoid Arthritis
7. Raven Announces Continued Enrollment of Phase 1/2a Clinical Trial of RAV12 Therapeutic Antibody for Treatment of Adenocarcinomas
8. Medarex Announces Allowance of Investigational New Drug Applications for Wholly Owned Fully Human Anti-CD19 Antibody, MDX-1342
9. Preclinical Studies Show Promise for Novel Antibody Therapy to Treat Acute Myeloid Leukemia (AML)
10. Celltrion and CSL Announce Collaboration to Develop and Manufacture Monoclonal Antibody
11. Micromet Announces the Publication of BiTE Antibody Review in Drugs of the Future
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... Statistics released from a number of organizations ... during the holidays, beginning with Thanksgiving eve, which is ... The data, highlighted in an Infographic ... of their annual Sober Days for the Holidays ... drinking and increased rates of DUI injuries and deaths ...
(Date:11/21/2014)... Mass. , Nov. 21, 2014  Alere Inc. ... rapid diagnostic tests, has appointed Juliet Cunningham ... role, Cunningham will be responsible for driving communications with ... execute on a series of changes to increase shareholder ... progress to investors," said Namal Nawana, Chief Executive Officer. ...
(Date:11/21/2014)... SARASOTA, Fla. , Nov. 21, 2014   ... ) announced that the Company is scheduled to present ... San Francisco, CA on January 12-14, ... PhD, Chairman and CEO of Rock Creek Pharmaceuticals, will ... small molecule cholinergic agonist which exhibits anti-inflammatory pharmacological characteristics. ...
Breaking Medicine Technology:Alarming Stats Show Holiday Drinking an Issue for Many 2Alere Appoints Juliet Cunningham to Lead Investor Relations 2Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 2Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 3Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 4
... than 60,000 young children end up in emergency rooms ... or caregivers were not looking. To remind parents and ... Centers for Disease Control and Prevention (CDC) and the ... with the PROTECT Initiative , today launched the ...
... 2011 Sotera Wireless, Inc. today announced the completion ... Singapore-based global fund, EDBI. The round also included new ... Ventures, Intel Capital and West Health Investment Fund. The ... with Cerner, a leading health care technology company, which ...
Cached Medicine Technology:CDC and CHPA Educational Foundation Launch Up and Away and Out of Sight 2CDC and CHPA Educational Foundation Launch Up and Away and Out of Sight 3Sotera Wireless Completes $12.2 Million Series D Financing, Signs Agreement with Cerner 2
(Date:11/23/2014)... (PRWEB) November 24, 2014 The ... H2, 2014" provides data on the Aspergillosis clinical ... data relating to the clinical trials on Aspergillosis. ... and their recruitment status as per the site ... offers a preliminary coverage of disease clinical trials ...
(Date:11/23/2014)... Dallas, TX (PRWEB) November 23, 2014 ... Energy Devices Market 2006 to 2020 - Asia-Pacific” ... and energy devices market segments: minimally invasive body ... resurfacing devices. The analysis includes market size data ... period for the following countries: China, Japan, South ...
(Date:11/23/2014)... New York, NY (PRWEB) November 23, 2014 ... ) that allege heart attacks, strokes, deep vein ... been filed in a federal multidistrict litigation (MDL) ... Liebhard LLP reports. , Court documents updated ... on Multidistrict Litigation (JPML) show the filing of ...
(Date:11/23/2014)... 2014 Locks-Magnetic.com, a notable magnetic locks ... all the new products are available at low rates ... is proud of the new emergency doors. The emergency ... customers can choose from several colors. All of the ... emergency door release is not as easy as many ...
(Date:11/23/2014)... 2014 SWAccessControl.com's high quality access control ... the company has announced its new collection of power ... these high quality power suppliers. All the new models ... special offer lasts until Dec. 20, 2014. , SWAccessControl.com ... have been supporting it for a long time. It ...
Breaking Medicine News(10 mins):Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 2Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 3Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 4Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 2Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 3Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 4Health News:Testosterone Lawsuits Approach 260 in Illinois Federal Court Litigation, Bernstein Liebhard LLP Reports 2Health News:Testosterone Lawsuits Approach 260 in Illinois Federal Court Litigation, Bernstein Liebhard LLP Reports 3Health News:Cheap Access Control Power Supplies Online Now at SWAccessControl.com, Special Offer Until Dec. 20, 2014 2
... City Hotel and Casino will host the 3rd ... ReceptionATLANTIC CITY, N.J., Feb. 17 The American ... are teaming up on Wednesday, February 25, 2009 ... Blood Donor Campaign awards reception.(Logo: http://www.newscom.com/cgi-bin/prnh/20090217/DC71647LOGO ...
... Six studies published in the past year by a Cornell ... -- as well as daily helpings of other fruits and ... one of his recent papers, published in the Journal ... Cornell associate professor of food science and a member of ...
... (Feb. 17, 2009) A research project at Rice ... long-standing medical mystery that may link cardiovascular disease, osteoporosis and ... thank the rat. , The recent paper in Artery ... team reports they have found that common rats with a ...
... TORONTO, Feb. 17 /PRNewswire/ - Sentinelle Medical Inc., ... software and Siemens Healthcare today announced an OEM ... agreement, Siemens will sell the "Sentinelle Vanguard for ... Espree, MAGNETOM(R) Avanto and MAGNETOM(R) Symphony, A Tim(TM) ...
... by wartime conditions, researchers say , , TUESDAY, Feb. 17 ... can be exacerbated by combat conditions in Iraq and ... being evacuated for treatment, a new report finds. , ... responsible for poor morale and combat ineffectiveness, the researchers ...
... from The University of Nottingham are taking to the streets ... are nearly twice the national average. , Reducing high levels ... which ranks third highest in the country after Corby and ... Control Studies and Professor in Health Policy and Promotion at ...
Cached Medicine News:Health News:The American Red Cross Recognizes Atlantic City Casinos 2Health News:In flurry of studies, researcher details role of apples in inhibiting breast cancer 2Health News:Mutant rats offer clues to medical mystery 2Health News:Mutant rats offer clues to medical mystery 3Health News:Sentinelle Medical Enters OEM Distribution Agreement with Siemens AG 2Health News:Sentinelle Medical Enters OEM Distribution Agreement with Siemens AG 3Health News:Skin Woes Take Toll on U.S. Combat Troops 2Health News:Skin Woes Take Toll on U.S. Combat Troops 3Health News:Investigating a community where smoking rates are double the national average 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: